News BioVaxys Technology Corp.

Equities

BIOV

CA09076M1014

Market Closed - Canadian Securities Exchange Other stock markets 01:05:54 16/05/2024 am IST			5-day change	1st Jan Change
0.07 ^CAD	0.00%		-6.67%	+40.00%

30/04	BioVaxys Technology Corp. Appoints Christopher Cherry as Chief Financial Officer	CI
10/04	Biovaxys and SpayVac-For-Wildlife, Inc. Announce Launch of Field Trial for Large-Scale Immunocontraception in the Commercial Aquatic Farming Industry	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BioVaxys Technology Corp. Announces Failure to File Cease Trade Order	16/05	AQ
CSE Bulletin: Suspension - BioVaxys Technology Corp. (BIOV)	16/05	NE
Canadian Investment Regulatory Organization Trading Halt - BIOV	16/05	AQ
BioVaxys Technology Corp. Closes SECOND Tranche of Private Placement	11/05	AQ
BioVaxys Technology Corp. Closes First Tranche of Private Placement	04/05	AQ
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	02/05	AQ
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050	01/05	AQ
BioVaxys Technology Corp. Appoints Christopher Cherry as Chief Financial Officer	30/04	CI
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	19/04	AQ
Biovaxys and SpayVac-For-Wildlife, Inc. Announce Launch of Field Trial for Large-Scale Immunocontraception in the Commercial Aquatic Farming Industry	10/04	CI
BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF FIELD TRIAL FOR LARGE-SCALE IMMUNOCONTRACEPTION IN THE COMMERCIAL AQUATIC FARMING INDUSTRY	10/04	AQ
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	05/04	AQ
BioVaxys Announces Allowance of DPX Formulation Patent for the United States and Filing of Additional International Patent Applications for Phase 1 DPX SurMage	03/04	CI
BioVaxys Technology Plans Private Placement; Down 5.9%	25/03	MT
BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT	23/03	AQ
BioVaxys Technology Corp. announced that it expects to receive CAD 1 million in funding	22/03	CI
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	22/03	AQ
Down 17%, BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	08/03	MT
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	08/03	AQ
BioVaxys Technology Corp. Announces Allowance of DPX-Related Patent for Japan and Filing of Additional International Patent Applications	05/03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News BioVaxys Technology Corp.

Equities

BIOV

CA09076M1014

Summary

Filters